https://www.nytimes.com/2024/01/17/health/us-drug-prices.html#:~:text=There%20are%20no%20price%20controls.&text=“Drugs%20are%20so%20expensive%20in,all%20engines%2C%20no%20brakes.”
A short article on US drug prices. On top of this, the US FDA is a hard nut to crack, it can cost 10s if not 100s of millions to get through the rigorous trial phases. So if a company gets approval, it tries to make as much as possible from their FDA approved products.
Ann: Euroz Hartleys Healthcare Forum Presentation, page-27
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |